Skip to content
lifestyle.californiaconsumerbanking.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
AxoSim Inc.
28bio Launches CNS-3D Alzheimer’s Model to Predict Therapeutic Efficacy
May 26, 2026
28bio Launches CNS-3D Inflammatory Organoids to Predict Anti-inflammatory Therapeutic Efficacy
May 19, 2026
28bio Launches CNS-3D Myelinated Organoids to Predict Therapeutic Efficacy
May 12, 2026
28bio’s Endurance Study Meets Primary Endpoint, Showing CNS-3D Brain Organoids Predict Clinical Seizure Liability
May 3, 2026